DK1237892T3 - Fremgangsmåde til fremstilling af epinastinhydrochlorid i den højtsmeltende krystalmodifikation - Google Patents

Fremgangsmåde til fremstilling af epinastinhydrochlorid i den højtsmeltende krystalmodifikation

Info

Publication number
DK1237892T3
DK1237892T3 DK00985110T DK00985110T DK1237892T3 DK 1237892 T3 DK1237892 T3 DK 1237892T3 DK 00985110 T DK00985110 T DK 00985110T DK 00985110 T DK00985110 T DK 00985110T DK 1237892 T3 DK1237892 T3 DK 1237892T3
Authority
DK
Denmark
Prior art keywords
preparation
crystal modification
epinastine hydrochloride
melting crystal
melting
Prior art date
Application number
DK00985110T
Other languages
English (en)
Inventor
Rolf Dach
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of DK1237892T3 publication Critical patent/DK1237892T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK00985110T 1999-12-03 2000-11-29 Fremgangsmåde til fremstilling af epinastinhydrochlorid i den højtsmeltende krystalmodifikation DK1237892T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19958460A DE19958460A1 (de) 1999-12-03 1999-12-03 Verfahren zur Herstellung von Epinastine-Hydrochlorid in der hochschmelzenden Kristallmodifikation
PCT/EP2000/011942 WO2001040229A2 (de) 1999-12-03 2000-11-29 Verfahren zur herstellung von epinastine-hydrochlorid in der hochschmelzenden kristallmodifikation

Publications (1)

Publication Number Publication Date
DK1237892T3 true DK1237892T3 (da) 2003-08-04

Family

ID=7931396

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00985110T DK1237892T3 (da) 1999-12-03 2000-11-29 Fremgangsmåde til fremstilling af epinastinhydrochlorid i den højtsmeltende krystalmodifikation

Country Status (23)

Country Link
US (1) US6403790B1 (da)
EP (1) EP1237892B1 (da)
JP (1) JP4789383B2 (da)
KR (1) KR100737191B1 (da)
CN (1) CN1402728A (da)
AR (1) AR026678A1 (da)
AT (1) ATE238306T1 (da)
AU (1) AU2163501A (da)
BR (1) BR0016052A (da)
CA (1) CA2389170C (da)
CO (1) CO5251470A1 (da)
CZ (1) CZ20021843A3 (da)
DE (2) DE19958460A1 (da)
DK (1) DK1237892T3 (da)
EA (1) EA200200630A1 (da)
ES (1) ES2198368T3 (da)
HU (1) HUP0203501A2 (da)
IL (1) IL149711A0 (da)
MX (1) MXPA02005330A (da)
PL (1) PL355628A1 (da)
PT (1) PT1237892E (da)
UY (1) UY26461A1 (da)
WO (1) WO2001040229A2 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
JP4298212B2 (ja) * 2002-03-29 2009-07-15 大日本印刷株式会社 塩酸エピナスチン高融点型結晶の製造法
EP1531802A1 (en) * 2002-08-02 2005-05-25 Boehringer Ingelheim International GmbH Pharmaceutical formulations comprising combinations of epinastine, pseudoephedrine and methylephedrine
KR101386530B1 (ko) 2006-12-29 2014-04-18 케이피엑스 라이프사이언스 주식회사 순도 및 수율이 향상된3-아미노-9,13b디하이드로-1H-디벤즈-[c,f]이미다조[1,5-a]-아제핀 염산염의 제조방법
CN104098575B (zh) * 2013-04-15 2016-06-01 四川科瑞德凯华制药有限公司 一种盐酸依匹斯汀晶型及其制备方法和用途
CN115448927A (zh) * 2022-10-20 2022-12-09 重庆瑞泊莱医药科技有限公司 一种氢溴酸依匹斯汀晶型ii及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3008944A1 (de) * 1980-03-08 1981-09-24 C.H. Boehringer Sohn, 6507 Ingelheim Dibenzimidazoazepine, ihre herstellung und verwendung
DE4102148A1 (de) * 1991-01-25 1992-07-30 Boehringer Ingelheim Kg Verfahren zur herstellung von 3-amino-9,13b-dihydro-1h-dibenz-(c,f)imidazol(1,5-a)azepin-hydrochlorid
JP3726291B2 (ja) * 1993-07-05 2005-12-14 三菱ウェルファーマ株式会社 安定な結晶構造を有するベンゾオキサジン化合物およびその製造法
JPH083160A (ja) * 1994-06-22 1996-01-09 Nippon Kayaku Co Ltd 6−(1−h−イミダゾール−1−イル)−7−ニトロ−2,3−(1h,4h)−キノキサリンジオン塩酸塩又は硫酸塩の分離精製法
JP3755908B2 (ja) * 1994-08-17 2006-03-15 塩野義製薬株式会社 セファロスポリン化合物の晶析法
JPH0948765A (ja) * 1995-08-04 1997-02-18 Toyama Chem Co Ltd 安定な結晶構造を有するトリアゾール誘導体およびその製造法
DE19542281C2 (de) * 1995-11-14 1997-12-04 Boehringer Ingelheim Kg Verwendung von Epinastin für die Behandlung der Migräne

Also Published As

Publication number Publication date
CA2389170C (en) 2008-01-08
HUP0203501A2 (hu) 2003-03-28
AR026678A1 (es) 2003-02-19
BR0016052A (pt) 2002-07-23
PL355628A1 (en) 2004-05-04
WO2001040229A2 (de) 2001-06-07
KR100737191B1 (ko) 2007-07-10
EP1237892B1 (de) 2003-04-23
CZ20021843A3 (cs) 2002-08-14
EA200200630A1 (ru) 2002-12-26
ES2198368T3 (es) 2004-02-01
UY26461A1 (es) 2001-07-31
US6403790B1 (en) 2002-06-11
IL149711A0 (en) 2002-11-10
AU2163501A (en) 2001-06-12
EP1237892A2 (de) 2002-09-11
CO5251470A1 (es) 2003-02-28
ATE238306T1 (de) 2003-05-15
WO2001040229A3 (de) 2001-12-06
DE19958460A1 (de) 2001-06-07
MXPA02005330A (es) 2003-01-28
JP2003515536A (ja) 2003-05-07
DE50001920D1 (de) 2003-05-28
CA2389170A1 (en) 2001-06-07
CN1402728A (zh) 2003-03-12
PT1237892E (pt) 2003-08-29
KR20020058080A (ko) 2002-07-12
JP4789383B2 (ja) 2011-10-12

Similar Documents

Publication Publication Date Title
DK1293507T3 (da) Fremgangsmåde til fremstilling af krystaller
DK1144395T3 (da) 2-amino-benzoxazinon-derivater til behandling af fedme
DK1275387T3 (da) Fremgangsmåde til fremstilling af farmaceutiske præparater af fenofibrat med höj biologisk tilgængelighed
DK1147083T3 (da) Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
DK1296935T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
DK3167872T3 (da) Fremgangsmåder til behandling af inflammationsmedierede tilstande i øjet
DK1232152T3 (da) Forbedret fremgangsmåde til fremstilling af nitrogensubstituerede aminotetraliner
DK1147075T3 (da) Fremgangsmåde til fremstilling af L-phenylephrinhydrochlorid
DK1231920T3 (da) Anvendelse af epinastin til behandling af allergisk rhinitis/conjunctivitis
DK1138677T3 (da) Fremgangsmåde til fremstilling af 11-amino-3-chlor-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]-thiazepin og anvendelse til syntese af tianeptin
DK0839138T3 (da) Fremgangsmåde til fremstilling af N-substituerede 3-hydroxypyrazoler
DK1187833T3 (da) Fremgangsmåde til fremstilling af thiamethoxam
DK1390330T3 (da) Integreret fremgangsmåde til fremstilling af alkyl- og alkenylsubstituerede aromatiske forbindelser
DK1456229T3 (da) Fremgangsmåe til fremstilling af echinocandin-derivater
DK1326836T3 (da) Fremgangsmåde til fremstilling af 3-amino-2-chlor-4-methylpyridin
DK1237892T3 (da) Fremgangsmåde til fremstilling af epinastinhydrochlorid i den højtsmeltende krystalmodifikation
NO20010782L (no) Krystalloscillator
DK0946514T3 (da) Fremgangsmåde til fremstilling af n-substituerede 3-hydroxypyrazoler
DK0973769T3 (da) Fremgangsmåde til fremstilling af eprosartan
DK0970073T3 (da) Fremgangsmåde til fremstilling af eprosartan
DK1268482T3 (da) Pyranoindoler til behandling af glaukom
DK1373232T3 (da) Fremgangsmåde til fremstilling af N-substituerede 2,6-dialkylmorpholiner
DK1159296T3 (da) Fremgangsmåde til fremstilling af cyclo-(Asp-DPhe-NMeVal-Arg-Gly)
DK1254159T3 (da) Fremgangsmåde til fremstilling af acetylamidiniophenylalanylcyclohexylglycylpyridylalaninamider
DE50003014D1 (de) N-substituierte perhydrodiazine